VECT-HORUS

About:

VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain.

Website: https://www.vect-horus.com/

Twitter/X: vecthorus

Top Investors: CAAP Creation, Incubateur Impulse, SCR Provençale et Corse, Financière Tuileries Co-Invest

Description:

VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain, organs, and tumors. The vectors target receptors involved in “Receptor-Mediated Transport” (RMT, a physiological system for the transport into cells of endogenous substances by combining drugs or imaging agents to its vectors, VECT-HORUS allows them to cross biological barriers that restrict access to their target, notably the blood-brain barrier (BBB). Founded in 2005 by Alexandre Tokay and Dr. Michel Khrestchatisky, the biotech company is based in Marseille, Marseille, Provence-Alpes-Cote d'Azur.

Total Funding Amount:

18M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Marseille, Provence-Alpes-Cote d'Azur, France

Founded Date:

2005-01-01

Contact Email:

contact(AT)vect-horus.com

Founders:

Alexandre Tokay, Dr. Michel KHRESTCHATISKY

Number of Employees:

11-50

Last Funding Date:

2020-12-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai